{"gene":"IER3IP1","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":2004,"finding":"IER3IP1 is a novel endoplasmic reticulum membrane protein containing a G-patch domain (suggested to be involved in RNA binding) and a C-terminal transmembrane domain; it localizes to the ER of HepG2 cells, confirmed by co-localization with an ER-specific marker.","method":"cDNA cloning, northern blot, co-localization with ER marker in HepG2 cells, transmembrane domain analysis","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with ER marker co-localization, single lab, two orthogonal methods (immunofluorescence + domain analysis)","pmids":["15276200"],"is_preprint":false},{"year":2010,"finding":"IER3IP1 gene transcription is activated by Sp1 binding to its basal promoter (-298/-59 region) and is induced by TNF-alpha through an NF-kappaB responsive element in the IER3IP1 promoter.","method":"Promoter deletion analysis, mutation analysis of Sp1 site, TNF-alpha treatment with NF-kappaB reporter assays","journal":"Cell biochemistry and function","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deletion and mutation analysis of promoter with functional readout, single lab, two orthogonal methods","pmids":["19885854"],"is_preprint":false},{"year":2017,"finding":"IER3IP1 knockdown in MIN6 beta-cells induces apoptosis associated with increased Bim and decreased Bcl-xL; knockdown of Bim or overexpression of Bcl-xL rescues this apoptosis. IER3IP1 suppression also impairs the IRE1 and PERK arms of the unfolded protein response (UPR) and decreases cell proliferation.","method":"shRNA knockdown in MIN6 cells, apoptosis assays, western blot for Bim/Bcl-xL/UPR markers, rescue experiments with Bim knockdown and Bcl-xL overexpression","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined cellular phenotype, multiple pathway markers, rescue experiments; single lab","pmids":["28915629"],"is_preprint":false},{"year":2022,"finding":"Constitutive or inducible beta-cell-specific deletion of IER3IP1 in mice causes severe early-onset insulin-deficient diabetes, markedly dilated beta-cell ER, increased proinsulin misfolding, elevated ER chaperones (PDI, ERO1, BiP, P58IPK), impaired beta-cell maturation and proliferation, and increased nuclear chromatin condensation.","method":"Conditional/inducible knockout mouse models (IER3IP1-βKO, IER3IP1-iβKO), electron microscopy of ER, islet transcriptome analysis, qRT-PCR, multiple independent approaches for beta-cell maturation/proliferation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent mouse KO models, multiple orthogonal methods (EM, transcriptomics, qRT-PCR, proliferation assays), single lab with rigorous controls","pmids":["36322741"],"is_preprint":false},{"year":2023,"finding":"IER3IP1 forms a complex with the Golgi transmembrane protein TMEM167A (Golgi transmembrane protein 167A) and limits activation of the unfolded protein response mediated by IRE1alpha and XBP1 in B cells; loss of IER3IP1 impairs B cell development in a hematopoietic-intrinsic manner.","method":"Forward genetic screen (ENU mutagenesis in mice), identification of hypomorphic Ier3ip1 allele, co-immunoprecipitation/complex formation assay, UPR marker analysis in B cells, hematopoietic transplantation to establish cell-intrinsic role","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal complex identification, epistasis via genetic screen, multiple orthogonal methods (co-IP, UPR markers, transplantation), single rigorous study","pmids":["37934820"],"is_preprint":false},{"year":2024,"finding":"IER3IP1 plays a non-essential role in ER-to-Golgi transport; its absence causes mistrafficking of neuronal development/survival proteins (FGFR3, UNC5B, SEMA4D), distension of ER membranes, increased lysosomal activity, compromised trafficking of cargo receptor ERGIC53 and KDEL-receptor 2, and anomalous secretion of ER-localized chaperones. In-utero knockdown of Ier3ip1 in mouse embryo brains causes morphological phenotype in newborn neurons.","method":"Secretome and cell-surface proteomics, in-utero knockdown of Ier3ip1 in mouse embryo brains, ER morphology analysis, lysosomal activity assays","journal":"Cellular and molecular life sciences : CMLS","confidence":"High","confidence_rationale":"Tier 2 / Strong — secretome and cell-surface proteomics with in vivo in-utero knockdown model, multiple orthogonal methods in single rigorous study","pmids":["39115595"],"is_preprint":false},{"year":2025,"finding":"Loss of IER3IP1 causes a ~3-fold reduction in ER-to-Golgi trafficking of proinsulin in human stem cell-derived beta-cells, leading to beta-cell dysfunction in vitro and in vivo, and triggers increased ER stress markers; this identifies impaired proinsulin trafficking as the molecular mechanism underlying IER3IP1-mutation-associated diabetes.","method":"Targeted genome editing (CRISPR) in human embryonic stem cells, differentiation into pancreatic islet lineages, ER-to-Golgi trafficking assay, in vivo transplantation, ER stress marker analysis","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1 / Strong — targeted genome editing with human stem cell differentiation model, quantitative trafficking assay, in vitro and in vivo validation, single rigorous study with multiple orthogonal methods","pmids":["39441964"],"is_preprint":false},{"year":2025,"finding":"IER3IP1 (Drosophila ortholog: Inseparable/Insep) is required for cytokinesis in neuroblasts; loss leads to cytokinesis failure and excessive accumulation of Rab11 vesicles in the cytoplasm. IER3IP1 localizes to Rab11 vesicles and physically interacts with Rab11. Pathogenic mutations in IER3IP1 perturb its localization to Rab11 vesicles. The Drosophila phenotype (small brains, early larval lethality) is rescued by expressing human IER3IP1, confirming functional conservation.","method":"Drosophila genetic screen, loss-of-function analysis, rescue with human IER3IP1, live imaging of Rab11 vesicles, co-immunoprecipitation with Rab11, IER3IP1 knockdown in human cells with cytokinesis assay, pathogenic mutation analysis of localization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue cross-species conservation, co-IP with Rab11, live-cell imaging, loss-of-function in both Drosophila and human cells, pathogenic mutation localization analysis; multiple orthogonal methods","pmids":["40991444"],"is_preprint":false}],"current_model":"IER3IP1 is a small ER membrane protein that facilitates ER-to-Golgi trafficking of specific cargo (including proinsulin, FGFR3, UNC5B, SEMA4D), localizes to and interacts with Rab11 recycling endosome vesicles to support cytokinesis, limits IRE1α/XBP1-mediated unfolded protein response activation in partnership with TMEM167A, and is transcriptionally regulated by Sp1 and TNF-α/NF-κB; loss of function causes ER distension, proinsulin misfolding, beta-cell apoptosis via Bim/Bcl-xL imbalance, impaired B cell development, and cytokinesis failure in neural stem cells."},"narrative":{"mechanistic_narrative":"IER3IP1 is a small endoplasmic reticulum membrane protein that supports the secretory pathway by facilitating ER-to-Golgi trafficking of specific cargo and by restraining ER stress [PMID:15276200, PMID:39115595]. It is required for the efficient export of secreted and membrane proteins, and its loss causes mistrafficking of neuronal development and survival factors (FGFR3, UNC5B, SEMA4D), distension of ER membranes, increased lysosomal activity, and aberrant secretion of ER-resident chaperones [PMID:39115595]. In pancreatic beta-cells, IER3IP1 is needed for ER-to-Golgi transport of proinsulin, and its loss reduces proinsulin trafficking, drives proinsulin misfolding with accumulation of ER chaperones (PDI, ERO1, BiP, P58IPK), and triggers ER stress and beta-cell apoptosis through a Bim/Bcl-xL imbalance, establishing impaired proinsulin trafficking as the basis of IER3IP1-associated insulin-deficient diabetes [PMID:28915629, PMID:36322741, PMID:39441964]. IER3IP1 forms a complex with the Golgi transmembrane protein TMEM167A and limits IRE1α/XBP1-mediated unfolded protein response activation, a function relevant to B cell development [PMID:37934820]. Beyond the secretory pathway, IER3IP1 localizes to and physically interacts with Rab11 recycling-endosome vesicles and is required for cytokinesis, with pathogenic mutations disrupting its Rab11-vesicle localization [PMID:40991444]. Its transcription is driven by Sp1 and induced by TNF-α via an NF-κB element [PMID:19885854].","teleology":[{"year":2004,"claim":"Established the basic identity and subcellular home of IER3IP1, defining it as an ER-resident membrane protein and providing the structural starting point for all later trafficking work.","evidence":"cDNA cloning, ER-marker co-localization, and transmembrane/domain analysis in HepG2 cells","pmids":["15276200"],"confidence":"Medium","gaps":["G-patch domain function in RNA binding never tested experimentally","No interacting partners or cargo identified at this stage","Topology and orientation in the ER membrane not resolved"]},{"year":2010,"claim":"Defined the transcriptional control of IER3IP1, linking its expression to Sp1 basal activity and inflammatory TNF-α/NF-κB signaling.","evidence":"Promoter deletion/mutation analysis with Sp1 site mapping and TNF-α/NF-κB reporter assays","pmids":["19885854"],"confidence":"Medium","gaps":["Physiological context in which TNF-α induction is relevant not established","No link drawn between transcriptional regulation and trafficking function"]},{"year":2017,"claim":"Connected IER3IP1 loss to beta-cell apoptosis through a defined Bim/Bcl-xL axis, providing the first mechanistic readout of why IER3IP1 deficiency damages beta-cells.","evidence":"shRNA knockdown in MIN6 cells with apoptosis assays, UPR/Bim/Bcl-xL westerns, and rescue by Bim knockdown or Bcl-xL overexpression","pmids":["28915629"],"confidence":"Medium","gaps":["Upstream cause of apoptosis (trafficking defect vs. direct UPR effect) not resolved","Reported suppression of IRE1/PERK arms here contrasts with later UPR-limiting findings","Single cell line, no in vivo validation"]},{"year":2022,"claim":"Demonstrated in vivo that beta-cell IER3IP1 is required to prevent ER distension, proinsulin misfolding, and insulin-deficient diabetes, anchoring the human disease phenotype in a genetic mouse model.","evidence":"Constitutive and inducible beta-cell-specific knockout mice with EM, islet transcriptomics, and proliferation/maturation assays","pmids":["36322741"],"confidence":"High","gaps":["Molecular trafficking step impaired not directly measured here","Whether ER distension is cause or consequence of misfolding unresolved"]},{"year":2023,"claim":"Identified TMEM167A as a physical partner and recast IER3IP1 as a limiter of IRE1α/XBP1 UPR signaling, extending its role beyond beta-cells to cell-intrinsic B cell development.","evidence":"ENU forward genetic screen yielding a hypomorphic allele, co-IP complex identification, UPR marker analysis, and hematopoietic transplantation","pmids":["37934820"],"confidence":"High","gaps":["Whether the TMEM167A complex mediates trafficking, UPR control, or both not separated","Structural basis of the IER3IP1–TMEM167A interaction unknown"]},{"year":2024,"claim":"Defined IER3IP1 as a selective ER-to-Golgi transport factor by identifying specific mistrafficked cargo and machinery, explaining the neurodevelopmental phenotype.","evidence":"Secretome and cell-surface proteomics, ER morphology and lysosomal activity assays, and in-utero knockdown in mouse embryo brains","pmids":["39115595"],"confidence":"High","gaps":["Mechanism of cargo selectivity not defined","Direct binding of IER3IP1 to the identified cargo not shown"]},{"year":2025,"claim":"Pinpointed impaired proinsulin ER-to-Golgi trafficking as the molecular mechanism of IER3IP1-mutation diabetes in a human stem cell-derived beta-cell system.","evidence":"CRISPR editing of human ESCs differentiated to islet lineages, quantitative ER-to-Golgi trafficking assay, ER stress markers, and in vivo transplantation","pmids":["39441964"],"confidence":"High","gaps":["Whether IER3IP1 directly packages proinsulin into transport carriers not established","Quantitative relationship between trafficking reduction and ER stress not modeled"]},{"year":2025,"claim":"Revealed a distinct Rab11-dependent role for IER3IP1 in cytokinesis, showing it localizes to and binds Rab11 vesicles and that disease mutations disrupt this localization, with cross-species rescue confirming conserved function.","evidence":"Drosophila genetic screen and human-gene rescue, Rab11 co-IP, live imaging of Rab11 vesicles, human-cell cytokinesis assays, and pathogenic mutation localization analysis","pmids":["40991444"],"confidence":"High","gaps":["How a single ER membrane protein bridges secretory trafficking and Rab11 recycling-endosome cytokinesis function unresolved","Whether Rab11 binding is direct or vesicle-membrane-mediated not distinguished"]},{"year":null,"claim":"It remains unknown how IER3IP1 mechanistically reconciles its dual roles in selective ER-to-Golgi cargo export and Rab11-vesicle-dependent cytokinesis, and what molecular feature confers cargo specificity.","evidence":"","pmids":[],"confidence":"High","gaps":["No structure of IER3IP1 or its complexes","No defined cargo-recognition mechanism","Relationship between TMEM167A complex and Rab11 association unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,3,5]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[5,6]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[4]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[7]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2]}],"complexes":[],"partners":["TMEM167A","RAB11"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y5U9","full_name":"Immediate early response 3-interacting protein 1","aliases":[],"length_aa":82,"mass_kda":9.0,"function":"Regulator of endoplasmic reticulum secretion that acts as a key determinant of brain size (PubMed:33122427). Required for secretion of extracellular matrix proteins (PubMed:33122427). Required for correct brain development by depositing sufficient extracellular matrix proteins for tissue integrity and the proliferation of neural progenitors (PubMed:33122427). Acts as a regulator of the unfolded protein response (UPR) (By similarity)","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q9Y5U9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/IER3IP1","classification":"Not Classified","n_dependent_lines":221,"n_total_lines":1208,"dependency_fraction":0.18294701986754966},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"YIPF5","stoichiometry":10.0},{"gene":"RER1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/IER3IP1","total_profiled":1310},"omim":[{"mim_id":"614231","title":"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1; MEDS1","url":"https://www.omim.org/entry/614231"},{"mim_id":"609382","title":"IMMEDIATE-EARLY RESPONSE 3-INTERACTING PROTEIN 1; IER3IP1","url":"https://www.omim.org/entry/609382"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Endoplasmic reticulum","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/IER3IP1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9Y5U9","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5U9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5U9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5U9-F1-predicted_aligned_error_v6.png","plddt_mean":61.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=IER3IP1","jax_strain_url":"https://www.jax.org/strain/search?query=IER3IP1"},"sequence":{"accession":"Q9Y5U9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y5U9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y5U9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5U9"}},"corpus_meta":[{"pmid":"22991235","id":"PMC_22991235","title":"A homozygous IER3IP1 mutation causes microcephaly with simplified gyral pattern, epilepsy, and permanent neonatal diabetes syndrome (MEDS).","date":"2012","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22991235","citation_count":43,"is_preprint":false},{"pmid":"24138066","id":"PMC_24138066","title":"Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in IER3IP1: insights into the natural history of a rare disorder.","date":"2013","source":"Pediatric diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/24138066","citation_count":39,"is_preprint":false},{"pmid":"15276200","id":"PMC_15276200","title":"Cloning and characterization of a novel endoplasmic reticulum localized G-patch domain protein, IER3IP1.","date":"2004","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15276200","citation_count":20,"is_preprint":false},{"pmid":"36322741","id":"PMC_36322741","title":"IER3IP1 is critical for maintaining glucose homeostasis through regulating the endoplasmic reticulum function and survival of β cells.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36322741","citation_count":16,"is_preprint":false},{"pmid":"28915629","id":"PMC_28915629","title":"IER3IP1 deficiency leads to increased β-cell death and decreased β-cell proliferation.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28915629","citation_count":15,"is_preprint":false},{"pmid":"37934820","id":"PMC_37934820","title":"Essential requirement for IER3IP1 in B cell development.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37934820","citation_count":8,"is_preprint":false},{"pmid":"39115595","id":"PMC_39115595","title":"IER3IP1-mutations cause microcephaly by selective inhibition of ER-Golgi transport.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/39115595","citation_count":7,"is_preprint":false},{"pmid":"36416459","id":"PMC_36416459","title":"A New Variant of the IER3IP1 Gene: The First Case of Microcephaly, Epilepsy, and Diabetes Syndrome 1 from Turkey.","date":"2022","source":"Journal of clinical research in pediatric endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36416459","citation_count":6,"is_preprint":false},{"pmid":"39441964","id":"PMC_39441964","title":"IER3IP1 Mutations Cause Neonatal Diabetes Due to Impaired Proinsulin Trafficking.","date":"2025","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/39441964","citation_count":5,"is_preprint":false},{"pmid":"19885854","id":"PMC_19885854","title":"Transcriptional regulation of IER3IP1 gene by tumor necrosis factor-alpha and Sp family proteins.","date":"2010","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/19885854","citation_count":2,"is_preprint":false},{"pmid":"18476594","id":"PMC_18476594","title":"[The expression of IER3IP1 gene in K562 cells treated by matrine and its effect on the cell growth].","date":"2007","source":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/18476594","citation_count":1,"is_preprint":false},{"pmid":"40991444","id":"PMC_40991444","title":"Inseparable/IER3IP1 are essential for cytokinesis in Drosophila neuroblasts and human cells.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40991444","citation_count":0,"is_preprint":false},{"pmid":"41200581","id":"PMC_41200581","title":"Microcephaly, Epilepsy, and Diabetes Syndrome 1: A Moroccan Case Report of Novel Compound Heterozygous IER3IP1 Mutations and Literature Review.","date":"2025","source":"Balkan journal of medical genetics : BJMG","url":"https://pubmed.ncbi.nlm.nih.gov/41200581","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.07.20.604396","title":"<i>Inseparable/IER3IP1</i>  are essential for cytokinesis in  <i>Drosophila</i>  neuroblast and human cells","date":"2024-07-23","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.20.604396","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8492,"output_tokens":2397,"usd":0.030715,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9482,"output_tokens":3224,"usd":0.064005,"stage2_stop_reason":"end_turn"},"total_usd":0.09472,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"IER3IP1 is a novel endoplasmic reticulum membrane protein containing a G-patch domain (suggested to be involved in RNA binding) and a C-terminal transmembrane domain; it localizes to the ER of HepG2 cells, confirmed by co-localization with an ER-specific marker.\",\n      \"method\": \"cDNA cloning, northern blot, co-localization with ER marker in HepG2 cells, transmembrane domain analysis\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with ER marker co-localization, single lab, two orthogonal methods (immunofluorescence + domain analysis)\",\n      \"pmids\": [\"15276200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"IER3IP1 gene transcription is activated by Sp1 binding to its basal promoter (-298/-59 region) and is induced by TNF-alpha through an NF-kappaB responsive element in the IER3IP1 promoter.\",\n      \"method\": \"Promoter deletion analysis, mutation analysis of Sp1 site, TNF-alpha treatment with NF-kappaB reporter assays\",\n      \"journal\": \"Cell biochemistry and function\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deletion and mutation analysis of promoter with functional readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"19885854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IER3IP1 knockdown in MIN6 beta-cells induces apoptosis associated with increased Bim and decreased Bcl-xL; knockdown of Bim or overexpression of Bcl-xL rescues this apoptosis. IER3IP1 suppression also impairs the IRE1 and PERK arms of the unfolded protein response (UPR) and decreases cell proliferation.\",\n      \"method\": \"shRNA knockdown in MIN6 cells, apoptosis assays, western blot for Bim/Bcl-xL/UPR markers, rescue experiments with Bim knockdown and Bcl-xL overexpression\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined cellular phenotype, multiple pathway markers, rescue experiments; single lab\",\n      \"pmids\": [\"28915629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Constitutive or inducible beta-cell-specific deletion of IER3IP1 in mice causes severe early-onset insulin-deficient diabetes, markedly dilated beta-cell ER, increased proinsulin misfolding, elevated ER chaperones (PDI, ERO1, BiP, P58IPK), impaired beta-cell maturation and proliferation, and increased nuclear chromatin condensation.\",\n      \"method\": \"Conditional/inducible knockout mouse models (IER3IP1-βKO, IER3IP1-iβKO), electron microscopy of ER, islet transcriptome analysis, qRT-PCR, multiple independent approaches for beta-cell maturation/proliferation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent mouse KO models, multiple orthogonal methods (EM, transcriptomics, qRT-PCR, proliferation assays), single lab with rigorous controls\",\n      \"pmids\": [\"36322741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"IER3IP1 forms a complex with the Golgi transmembrane protein TMEM167A (Golgi transmembrane protein 167A) and limits activation of the unfolded protein response mediated by IRE1alpha and XBP1 in B cells; loss of IER3IP1 impairs B cell development in a hematopoietic-intrinsic manner.\",\n      \"method\": \"Forward genetic screen (ENU mutagenesis in mice), identification of hypomorphic Ier3ip1 allele, co-immunoprecipitation/complex formation assay, UPR marker analysis in B cells, hematopoietic transplantation to establish cell-intrinsic role\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal complex identification, epistasis via genetic screen, multiple orthogonal methods (co-IP, UPR markers, transplantation), single rigorous study\",\n      \"pmids\": [\"37934820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"IER3IP1 plays a non-essential role in ER-to-Golgi transport; its absence causes mistrafficking of neuronal development/survival proteins (FGFR3, UNC5B, SEMA4D), distension of ER membranes, increased lysosomal activity, compromised trafficking of cargo receptor ERGIC53 and KDEL-receptor 2, and anomalous secretion of ER-localized chaperones. In-utero knockdown of Ier3ip1 in mouse embryo brains causes morphological phenotype in newborn neurons.\",\n      \"method\": \"Secretome and cell-surface proteomics, in-utero knockdown of Ier3ip1 in mouse embryo brains, ER morphology analysis, lysosomal activity assays\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — secretome and cell-surface proteomics with in vivo in-utero knockdown model, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"39115595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Loss of IER3IP1 causes a ~3-fold reduction in ER-to-Golgi trafficking of proinsulin in human stem cell-derived beta-cells, leading to beta-cell dysfunction in vitro and in vivo, and triggers increased ER stress markers; this identifies impaired proinsulin trafficking as the molecular mechanism underlying IER3IP1-mutation-associated diabetes.\",\n      \"method\": \"Targeted genome editing (CRISPR) in human embryonic stem cells, differentiation into pancreatic islet lineages, ER-to-Golgi trafficking assay, in vivo transplantation, ER stress marker analysis\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — targeted genome editing with human stem cell differentiation model, quantitative trafficking assay, in vitro and in vivo validation, single rigorous study with multiple orthogonal methods\",\n      \"pmids\": [\"39441964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"IER3IP1 (Drosophila ortholog: Inseparable/Insep) is required for cytokinesis in neuroblasts; loss leads to cytokinesis failure and excessive accumulation of Rab11 vesicles in the cytoplasm. IER3IP1 localizes to Rab11 vesicles and physically interacts with Rab11. Pathogenic mutations in IER3IP1 perturb its localization to Rab11 vesicles. The Drosophila phenotype (small brains, early larval lethality) is rescued by expressing human IER3IP1, confirming functional conservation.\",\n      \"method\": \"Drosophila genetic screen, loss-of-function analysis, rescue with human IER3IP1, live imaging of Rab11 vesicles, co-immunoprecipitation with Rab11, IER3IP1 knockdown in human cells with cytokinesis assay, pathogenic mutation analysis of localization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue cross-species conservation, co-IP with Rab11, live-cell imaging, loss-of-function in both Drosophila and human cells, pathogenic mutation localization analysis; multiple orthogonal methods\",\n      \"pmids\": [\"40991444\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"IER3IP1 is a small ER membrane protein that facilitates ER-to-Golgi trafficking of specific cargo (including proinsulin, FGFR3, UNC5B, SEMA4D), localizes to and interacts with Rab11 recycling endosome vesicles to support cytokinesis, limits IRE1α/XBP1-mediated unfolded protein response activation in partnership with TMEM167A, and is transcriptionally regulated by Sp1 and TNF-α/NF-κB; loss of function causes ER distension, proinsulin misfolding, beta-cell apoptosis via Bim/Bcl-xL imbalance, impaired B cell development, and cytokinesis failure in neural stem cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"IER3IP1 is a small endoplasmic reticulum membrane protein that supports the secretory pathway by facilitating ER-to-Golgi trafficking of specific cargo and by restraining ER stress [#0, #5]. It is required for the efficient export of secreted and membrane proteins, and its loss causes mistrafficking of neuronal development and survival factors (FGFR3, UNC5B, SEMA4D), distension of ER membranes, increased lysosomal activity, and aberrant secretion of ER-resident chaperones [#5]. In pancreatic beta-cells, IER3IP1 is needed for ER-to-Golgi transport of proinsulin, and its loss reduces proinsulin trafficking, drives proinsulin misfolding with accumulation of ER chaperones (PDI, ERO1, BiP, P58IPK), and triggers ER stress and beta-cell apoptosis through a Bim/Bcl-xL imbalance, establishing impaired proinsulin trafficking as the basis of IER3IP1-associated insulin-deficient diabetes [#2, #3, #6]. IER3IP1 forms a complex with the Golgi transmembrane protein TMEM167A and limits IRE1\\u03b1/XBP1-mediated unfolded protein response activation, a function relevant to B cell development [#4]. Beyond the secretory pathway, IER3IP1 localizes to and physically interacts with Rab11 recycling-endosome vesicles and is required for cytokinesis, with pathogenic mutations disrupting its Rab11-vesicle localization [#7]. Its transcription is driven by Sp1 and induced by TNF-\\u03b1 via an NF-\\u03baB element [#1].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established the basic identity and subcellular home of IER3IP1, defining it as an ER-resident membrane protein and providing the structural starting point for all later trafficking work.\",\n      \"evidence\": \"cDNA cloning, ER-marker co-localization, and transmembrane/domain analysis in HepG2 cells\",\n      \"pmids\": [\"15276200\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"G-patch domain function in RNA binding never tested experimentally\",\n        \"No interacting partners or cargo identified at this stage\",\n        \"Topology and orientation in the ER membrane not resolved\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the transcriptional control of IER3IP1, linking its expression to Sp1 basal activity and inflammatory TNF-\\u03b1/NF-\\u03baB signaling.\",\n      \"evidence\": \"Promoter deletion/mutation analysis with Sp1 site mapping and TNF-\\u03b1/NF-\\u03baB reporter assays\",\n      \"pmids\": [\"19885854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Physiological context in which TNF-\\u03b1 induction is relevant not established\",\n        \"No link drawn between transcriptional regulation and trafficking function\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Connected IER3IP1 loss to beta-cell apoptosis through a defined Bim/Bcl-xL axis, providing the first mechanistic readout of why IER3IP1 deficiency damages beta-cells.\",\n      \"evidence\": \"shRNA knockdown in MIN6 cells with apoptosis assays, UPR/Bim/Bcl-xL westerns, and rescue by Bim knockdown or Bcl-xL overexpression\",\n      \"pmids\": [\"28915629\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Upstream cause of apoptosis (trafficking defect vs. direct UPR effect) not resolved\",\n        \"Reported suppression of IRE1/PERK arms here contrasts with later UPR-limiting findings\",\n        \"Single cell line, no in vivo validation\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated in vivo that beta-cell IER3IP1 is required to prevent ER distension, proinsulin misfolding, and insulin-deficient diabetes, anchoring the human disease phenotype in a genetic mouse model.\",\n      \"evidence\": \"Constitutive and inducible beta-cell-specific knockout mice with EM, islet transcriptomics, and proliferation/maturation assays\",\n      \"pmids\": [\"36322741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular trafficking step impaired not directly measured here\",\n        \"Whether ER distension is cause or consequence of misfolding unresolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified TMEM167A as a physical partner and recast IER3IP1 as a limiter of IRE1\\u03b1/XBP1 UPR signaling, extending its role beyond beta-cells to cell-intrinsic B cell development.\",\n      \"evidence\": \"ENU forward genetic screen yielding a hypomorphic allele, co-IP complex identification, UPR marker analysis, and hematopoietic transplantation\",\n      \"pmids\": [\"37934820\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the TMEM167A complex mediates trafficking, UPR control, or both not separated\",\n        \"Structural basis of the IER3IP1\\u2013TMEM167A interaction unknown\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined IER3IP1 as a selective ER-to-Golgi transport factor by identifying specific mistrafficked cargo and machinery, explaining the neurodevelopmental phenotype.\",\n      \"evidence\": \"Secretome and cell-surface proteomics, ER morphology and lysosomal activity assays, and in-utero knockdown in mouse embryo brains\",\n      \"pmids\": [\"39115595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism of cargo selectivity not defined\",\n        \"Direct binding of IER3IP1 to the identified cargo not shown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Pinpointed impaired proinsulin ER-to-Golgi trafficking as the molecular mechanism of IER3IP1-mutation diabetes in a human stem cell-derived beta-cell system.\",\n      \"evidence\": \"CRISPR editing of human ESCs differentiated to islet lineages, quantitative ER-to-Golgi trafficking assay, ER stress markers, and in vivo transplantation\",\n      \"pmids\": [\"39441964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether IER3IP1 directly packages proinsulin into transport carriers not established\",\n        \"Quantitative relationship between trafficking reduction and ER stress not modeled\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Revealed a distinct Rab11-dependent role for IER3IP1 in cytokinesis, showing it localizes to and binds Rab11 vesicles and that disease mutations disrupt this localization, with cross-species rescue confirming conserved function.\",\n      \"evidence\": \"Drosophila genetic screen and human-gene rescue, Rab11 co-IP, live imaging of Rab11 vesicles, human-cell cytokinesis assays, and pathogenic mutation localization analysis\",\n      \"pmids\": [\"40991444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How a single ER membrane protein bridges secretory trafficking and Rab11 recycling-endosome cytokinesis function unresolved\",\n        \"Whether Rab11 binding is direct or vesicle-membrane-mediated not distinguished\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how IER3IP1 mechanistically reconciles its dual roles in selective ER-to-Golgi cargo export and Rab11-vesicle-dependent cytokinesis, and what molecular feature confers cargo specificity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structure of IER3IP1 or its complexes\",\n        \"No defined cargo-recognition mechanism\",\n        \"Relationship between TMEM167A complex and Rab11 association unexplored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 3, 5]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TMEM167A\",\n      \"RAB11\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}